LB PHARMACEUTICALS INC (LBRX) (CIK 0001691082) (LBRX)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 10, 2026 | CORRESP | Neutral/Informational | Moderate | LB Pharmaceuticals Inc has submitted a request to the U.S. Securities and Exchange Commission to expedite the effectiveness of their Registration Statement on Form S-1. They are s… | Read Filing EDGAR |
| Apr. 10, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated April 10, 2026, informs LB Pharmaceuticals Inc that their registration statement on Form S-1, filed on April 6, 2026, will not be reviewed by the SEC.… | Read Filing EDGAR |
| Sep. 9, 2025 | CORRESP | Neutral/Informational | Moderate | LB Pharmaceuticals Inc has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. The company is seeking to have the registra… | Read Filing EDGAR |
| Sep. 9, 2025 | CORRESP | Neutral/Informational | Moderate | LB Pharmaceuticals Inc has submitted a request to the SEC to accelerate the effective date of their amended Registration Statement on Form S-1. The request aims for the statement … | Read Filing EDGAR |
| Sep. 3, 2025 | CORRESP | Neutral/Informational | - | No summary returned. | Read Filing EDGAR |
| Aug. 22, 2025 | CORRESP | Neutral/Informational | Moderate | LB Pharmaceuticals Inc submitted a response to the SEC regarding comments on their Amendment No. 2 to the Draft Registration Statement on Form S-1. The correspondence addresses sp… | Read Filing EDGAR |
| Aug. 12, 2025 | UPLOAD | Concern from SEC | Moderate | The SEC has reviewed LB Pharmaceuticals Inc's amended draft registration statement and provided comments that require a response. The SEC highlights the need for clearer disclosur… | Read Filing EDGAR |